Signaling pathways
-
BA5276 DexloxiglumideSummary: Dexloxiglumide is a selective cholecystokinin type A receptor antagonist. -
BA5277 TarazepideSummary: A potent and specific receptor antagonist. -
BA5278 BenzotriptSummary: Benzotript (Benzotriptum) is a cholecystokinin receptor and gastrin receptor antagonist. -
BA5279 R121919Summary: R121919 (NBI30775) is a potent, selective antagonist. -
BA5280 VerucerfontSummary: Verucerfont is an antagonist of adrenocorticotropin-releasing factor receptor 1. -
BA5281 NBI-27914Summary: NBI-27914 is a potent and selective CRFR1 antagonist. -
BA5282 TildacerfontSummary: Tildacerfont is a potent and orally active inhibitor. -
BA5283 PexacerfontSummary: Pexacerfont is a selective adrenocorticotropin-releasing factor receptor antagonist. -
BA5284 AntalarminSummary: Antalarmin is a selective nonpeptide adrenocorticotropic hormone releasing factor receptor 1 antagonist. -
BA5285 EmicerfontSummary: Emicerfont is a proadrenocorticotropic hormone releasing factor type 1 receptor antagonist.

